Form 4: Perrigo Executive Alison Ives Reports Stock Transactions

Alison Ives, EVP & Chief Scientific Officer of Perrigo Co plc, reports the acquisition and disposal of ordinary shares and the exercising of restricted stock units on July 8, 2024.

Summary

• On July 8, 2024, Alison Ives, EVP & Chief Scientific Officer of Perrigo Co plc, reported transactions involving the company's ordinary shares.
• Ives acquired 920 ordinary shares at a price of $25.72 per share through the exercising of restricted stock units.
• Concurrently, Ives disposed of 479 ordinary shares at $25.72 per share to cover tax obligations.
• Following these transactions, Ives directly owns 18,451 ordinary shares.
• The transactions were related to the vesting of restricted stock units in three equal annual installments beginning July 8, 2023.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document simply reports stock transactions by an executive, which is a routine occurrence. The exercising of options and vesting of restricted stock units is generally a positive sign, but the sale of shares to cover taxes is a normal part of the process.

Positives

• The exercising of stock options and vesting of restricted stock units by executives can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are regularly reported to the SEC. These transactions can provide insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders, as they represent a small percentage of the company's outstanding shares.
• However, stakeholders may interpret these transactions as a signal of management's confidence (or lack thereof) in the company's future performance.

Key Dates